Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort

Surgery. 2018 Nov;164(5):1093-1099. doi: 10.1016/j.surg.2018.06.026. Epub 2018 Jul 31.

Abstract

Background: Desmoplastic reaction of the mesentery is commonly seen in patients with neuroendocrine tumors of the small intestine. However, it is not clear whether desmoplastic reaction is associated with tumor-specific characteristics and diminished prognosis. Therefore, the aim of this study was to investigate whether the presence of a desmoplastic reaction correlates with prognostic and molecular markers of neuroendocrine tumors of the small intestine.

Methods: Patients with neuroendocrine tumors of the small intestine operated at our department from 2000 to 2016 were analyzed. Patient and tumor characteristics were evaluated. Kaplan-Meier and multivariate analyses were performed.

Results: In total, 148 patients underwent surgery, and preoperative imaging was available in 113 patients. A total of 45 patients showed desmoplastic reaction of the mesentery and progression-free survival was significantly impaired (26 months versus 65.4 months) compared with patients without desmoplastic reaction. These patients had significantly more often distant metastases (84.4% vs 39.7%), lymphatic vessel (68.9% vs 44.1%), and perineural tissue infiltration (57.8% vs 17.6%) compared with patients without desmoplastic reaction. However, proliferation index (positive desmoplastic reaction 4.1% versus negative desmoplastic reaction 3.3%) and tumor size (positive desmoplastic reaction 2 cm versus negative desmoplastic reaction 1.9 cm) were not diverging significantly.

Conclusion: This study revealed that tumors leading to desmoplastic reaction are more aggressive, despite similar Ki67 indices.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fibrosis
  • Humans
  • Intestinal Neoplasms / blood
  • Intestinal Neoplasms / mortality
  • Intestinal Neoplasms / pathology*
  • Intestinal Neoplasms / surgery
  • Intestine, Small / pathology
  • Intestine, Small / surgery
  • Ki-67 Antigen / blood*
  • Male
  • Mesentery / diagnostic imaging
  • Mesentery / pathology*
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Neuroendocrine Tumors / blood
  • Neuroendocrine Tumors / mortality
  • Neuroendocrine Tumors / pathology*
  • Neuroendocrine Tumors / surgery
  • Prognosis
  • Progression-Free Survival
  • Prospective Studies
  • Tomography, X-Ray Computed

Substances

  • Ki-67 Antigen
  • MKI67 protein, human